- Home
- DDI vs MREO Comparison
DDI vs MREO Comparison
Compare DDI & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- MREO
- Stock Information
- Founded
- DDI 2008
- MREO 2015
- Country
- DDI South Korea
- MREO United Kingdom
- Employees
- DDI N/A
- MREO N/A
- Industry
- DDI EDP Services
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- MREO Health Care
- Exchange
- DDI Nasdaq
- MREO Nasdaq
- Market Cap
- DDI 489.1M
- MREO 424.5M
- IPO Year
- DDI 2021
- MREO N/A
- Fundamental
- Price
- DDI $8.90
- MREO $2.85
- Analyst Decision
- DDI Strong Buy
- MREO Strong Buy
- Analyst Count
- DDI 4
- MREO 7
- Target Price
- DDI $20.50
- MREO $7.71
- AVG Volume (30 Days)
- DDI 106.5K
- MREO 1.2M
- Earning Date
- DDI 08-11-2025
- MREO 08-12-2025
- Dividend Yield
- DDI N/A
- MREO N/A
- EPS Growth
- DDI 9.79
- MREO N/A
- EPS
- DDI 2.37
- MREO N/A
- Revenue
- DDI $336,679,000.00
- MREO N/A
- Revenue This Year
- DDI $8.25
- MREO N/A
- Revenue Next Year
- DDI $3.39
- MREO $54.07
- P/E Ratio
- DDI $3.70
- MREO N/A
- Revenue Growth
- DDI 5.41
- MREO N/A
- 52 Week Low
- DDI $8.09
- MREO $1.58
- 52 Week High
- DDI $18.21
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- DDI 39.97
- MREO 64.74
- Support Level
- DDI $8.52
- MREO $2.61
- Resistance Level
- DDI $9.43
- MREO $2.85
- Average True Range (ATR)
- DDI 0.45
- MREO 0.17
- MACD
- DDI -0.16
- MREO 0.03
- Stochastic Oscillator
- DDI 28.84
- MREO 88.83
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).